Point72 Asset Management
ABOS icon

Point72 Asset Management’s Acumen Pharmaceuticals ABOS Stock Holding History

Point72 Asset Management’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$159K Buy
67,375
+31,010
+85% +$79.1K ﹤0.01% 3563
2025
Q4 		$76.7K Buy
+36,365
New +$72.1K ﹤0.01% 3759
2023
Q2 		– Sell
-3,954
Closed -$16.1K – 2109
2023
Q1 		$16.1K Buy
+3,954
New +$20.6K ﹤0.01% 1996
2022
Q4 		– Sell
-40,936
Closed -$411K – 1476
2022
Q3 		$411K Buy
+40,936
New +$235K ﹤0.01% 1196
2022
Q2 		– Sell
-55,054
Closed -$215K – 1380
2022
Q1 		$215K Buy
+55,054
New +$300K ﹤0.01% 1060

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Point72 Asset Management's ABOS Position: Q1 2026 in Review

Point72 Asset Management increased its Acumen Pharmaceuticals (ABOS) stake by 85% in Q1 2026, buying an estimated $79.1K and bringing the position to 67,375 shares worth $159K. The position accounts for ﹤0.01% of the portfolio, ranked #3563.

Point72 Asset Management first reported a position in ABOS in Q1 2022 and has held it in 5 quarters since. The position peaked at $411K in Q3 2022. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Point72 Asset Management held 67,375 shares of Acumen Pharmaceuticals worth $159K as of Q1 2026.
  • Point72 Asset Management bought 31,010 Acumen Pharmaceuticals shares in Q1 2026, an estimated $79.1K.
  • Acumen Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #3563 holding.
  • Point72 Asset Management first reported a position in Acumen Pharmaceuticals in Q1 2022 and has held it in 5 quarters since.
  • Point72 Asset Management's Acumen Pharmaceuticals position peaked at $411K in Q3 2022.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.